Acute Lymphoblastic Leukemia ,Lymphomas: Clinical Trials

2 trials for Acute Lymphoblastic Leukemia ,Lymphomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1
Phase 11Unknown 1
Phase 21Unknown 1

Follow Acute Lymphoblastic Leukemia ,Lymphomas: new trials by email Literature Review of Acute Lymphoblastic Leukemia ,Lymphomas trials Research Report on Acute Lymphoblastic Leukemia ,Lymphomas

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
my.naviGATE Digital Tool - Sarcoma, Osteosarcoma
Not applicableNot yet recruitingDana-Farber Cancer Institute1432026-11-202026-10-29
Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas
Anti-CD19 CAR-T - Acute Lymphoblastic Leukemia ,Lymphomas
Phase 1 / Phase 2UnknownThe First Affiliated Hospital of Nanchang University202019-12-012019-12-12

Narrower conditions

Leukemia, Myeloid, Acute (1)  ·  Medulloblastoma (1)  ·  Osteosarcoma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)

Broader conditions

Glioma (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Myosarcoma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)

Sponsors

Dana-Farber Cancer Institute (1)  ·  The First Affiliated Hospital of Nanchang University (1)

Countries

China (1)  ·  United States (1)

Top investigators

Katie Greenzang, MD (1)